Trade Ideas November 14, 2026 05:59 AM

Teleperformance at a Discount: Buy the Yield, Back the Turnaround

High dividend, low multiples and AI-enabled growth make TLPFY a contrarian long with a clear risk-reward

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
TLPFY

Teleperformance (TLPFY) trades at a sub-1x book and an 8.4x P/E while yielding ~4.8%. Operational momentum from AI-driven services and repeated regional recognitions give a plausible path to a multiple re-rate. This trade idea lays out an actionable long with entry, stop and target, plus catalysts and risks to monitor.

Teleperformance at a Discount: Buy the Yield, Back the Turnaround
TLPFY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • TLPFY trades at P/E ~8.4 and P/B ~0.95, offering deep-value entry relative to historical norms for global outsourcing firms.
  • Dividend of $1.8886 per share yields ~4.81%, providing income while waiting for multiple expansion.
  • AI and digital service adoption are tangible growth levers that could drive margin expansion and re-rating.
  • Trade plan: buy $39.50, stop $34.00, target $46.00, horizon long term (180 trading days).

Hook & thesis

Teleperformance (TLPFY) is offering what value investors wait for: a market-capitalization of roughly $4.78 billion, earnings multiple near 8.4x, and a price-to-book below 1.0, yet a business that still collects predictable cash flow from global customer-experience outsourcing. At the current price near $39.93, you can buy a high-yielding (4.81%) franchise with clear operational levers from AI and digital transformation and a history of steady client retention.

My view: buy a disciplined size position here with the plan to hold through execution on AI-enabled services and potential multiple expansion. The immediate trade is tactical - capture the mispriced yield and earnings multiple while monitoring execution and geopolitical headwinds.

What the company does and why it matters

Teleperformance provides business process outsourcing, customer relationship management, telemarketing and technical support to a wide set of verticals including banking, healthcare, retail, telecom and video games. The firm runs regionally segmented operations (English-speaking & APAC; Ibero-LATAM; Continental Europe & MEA; India & Middle East) and combines human agents with digital/AI tools to manage customer journeys at scale.

Why the market should care: the global customer experience outsourcing market is expected to continue growing as enterprise clients shift to blended human-plus-AI models. Teleperformance has earned repeated industry recognition (for example, multi-year Frost Radar placement in Asia-Pacific) and is pushing initiatives to help large brands globalize with AI and deep localization. That positions it to convert client transformation budgets into higher-value service contracts.

Hard numbers that support the trade

Here are the concrete items that justify a value approach:

  • Market cap: approximately $4.78 billion.
  • Valuation: P/E ~8.43 and P/B ~0.95, both signaling a low market multiple relative to a profitable services company.
  • Dividend: cash distribution of $1.8886 per share paid annually, implying a yield of ~4.81% at current levels. Ex-dividend was 05/22/2026 and payable on 06/17/2026, demonstrating management’s willingness to return cash.
  • Share count and liquidity: ~119.75 million shares outstanding and a free float of ~115.11 million; trading volumes have a two-week average near ~10,167 shares, though recent daily volumes show episodic spikes.
  • Price action: 52-week range $25.70 - $46.10; current price around $39.93 sits comfortably above the mid-2026 low but well below the recent high, leaving room to re-test the $46 area on renewed confidence.

Technical and market context

Short-term momentum is mixed. The 10-day simple moving average sits near $40.88 and the 20-day near $42.55, with the 50-day at $41.23; the stock recently traded slightly below several short-term averages and the MACD signals bearish momentum. RSI is neutral-bearish at ~44. Short interest has generally been low on days-to-cover metrics, but recent short-volume spikes indicate some traders are actively betting on near-term weakness. This technical backdrop supports a cautious, size-limited entry with defined stops.

Valuation framing

Using the snapshot: trading at ~8.4x earnings and under 1x book value is atypical for a multi-national services firm with recurring revenue and demonstrable cash returns through dividends. Without peer multiples in this note, the logic is simple: if Teleperformance can sustain margins and convert a portion of revenue into free cash flow while keeping client retention high, the current multiples look conservative. The dividend yield near 4.8% adds an immediate income cushion for patience while the market re-assesses the company’s growth optionality tied to AI-enabled services.

Trade plan - actionable entry, stop and target

Structure this as a conviction long with a clear time horizon and risk budget.

  • Entry: Limit order at $39.50. This is a reasonable entry near current levels that leaves some room against intra-day pops.
  • Stop loss: $34.00. Place a hard stop below recent consolidation to protect capital if earnings or macro shocks hit demand for outsourcing services.
  • Target: $46.00. This target lines up with the 52-week high ($46.10) and represents a logical re-rating point if results and AI-driven growth accelerate.
  • Trade size & risk: Keep position size such that the dollar loss to the stop does not exceed your portfolio risk tolerance (commonly 1-2% of portfolio capital).
  • Horizon: long term (180 trading days). Expect the path to re-rating and dividend capture to take multiple quarters as contracts renew and AI services scale. If catalysts accelerate, consider trimming earlier.

Catalysts that could drive the re-rate

  • Better-than-expected quarterly results showing margin expansion from AI/digital mix and improved pricing on new contracts.
  • Announcements of large multi-year deals with enterprise clients that shift work to Teleperformance’s higher-margin digital offerings.
  • Positive regional developments: expansion or market-share gains in high-growth APAC or LATAM markets where Teleperformance already has scale and recognition.
  • Corporate actions such as higher dividend guidance, share buybacks, or improved transparency on capital allocation that would reduce the discount for being a Pink/OTC-listed ADR.

Risks and counterarguments

There are concrete reasons the market is skeptical and they deserve respect:

  • Execution risk on digital/AI transition. Converting legacy, labor-heavy contracts into higher-margin digital offerings takes time; failure to do so would keep margins compressed and justify the low multiple.
  • Geopolitical and regulatory exposure. Teleperformance operates across many jurisdictions. Data privacy, labor disputes or regulatory tightening in key markets (Europe, LATAM, APAC) could raise costs or interrupt operations.
  • Customer concentration and contract risk. Outsourcing revenues can be lumpy; the loss or downsizing of a few large clients would materially damage revenue and sentiment.
  • Listing and liquidity discount. Trading in the Pink/OTC space often carries a persistent liquidity and disclosure discount relative to primary exchanges, which can keep the stock range-bound despite improving fundamentals.
  • Macro slowdown and corporate spend cuts. If enterprises cut customer-experience budgets during a downturn, outsourcing demand could decline, pressuring revenue and margins.

Counterargument to the thesis: One plausible bear case is that Teleperformance's low multiple reflects structural concerns—slowing revenue growth, permanent margin pressure from wage inflation, and weaker demand for outsourced services as companies automate in-house. If these structural problems persist, the dividend yield becomes a value trap rather than a cushion. That outcome would likely push the stock back toward the low end of its 52-week range.

What would change my mind

I will reduce conviction or exit if any of the following occur:

  • Quarterly results show a material, sustained drop in client retention or revenue per client with no compensating margin improvements.
  • Management cuts or suspends the dividend or signals capital constraints impacting buybacks or payouts.
  • Regulatory events materially increase operating costs (for example, fines or material restrictions on cross-border data handling in a key market).

Conclusion

Teleperformance looks like a classic deep-value opportunity: attractive income via a near 4.8% yield, low multiples (P/E ~8.4, P/B <1) and optionality from AI/digital service expansion. The trade outlined - buy at $39.50, stop at $34.00, target $46.00, horizon long term (180 trading days) - balances capture of the dividend and upside from a re-rate while protecting downside if execution or macro trends disappoint. Size the position modestly, monitor quarterly execution and regulatory headlines, and use the stop to enforce discipline.

Metric Value
Current price $39.93
Market cap $4.78B
P/E 8.43
P/B 0.95
Dividend yield 4.81%
52-week range $25.70 - $46.10

Key monitoring items after entry

  • Quarterly revenue growth and margin trends, especially any signs of incremental margin from AI/digital work.
  • Dividend policy updates and capital allocation commentary.
  • Major client wins/losses and regional operational disruptions.
  • Liquidity shifts and short-volume behavior that could signal rising speculative pressure.

Trade summary: Buy $39.50, Stop $34.00, Target $46.00, Horizon: long term (180 trading days), Risk level: medium.

Risks

  • Execution risk converting legacy contracts to higher-margin AI/digital offerings.
  • Regulatory or data-privacy actions in key jurisdictions that raise operating costs.
  • Listing and liquidity discount from OTC/Pink-tier trading could keep multiples depressed.
  • Macro-driven cuts to corporate outsourcing budgets could materially weaken revenue.

More from Trade Ideas

Playing the Investor Day: A Tactical Nike (NKE) Swing Trade Around Management’s Roadmap Nov 14, 2026 Buy the Bloodbath: 2 Reasons Nebius (NBIS) Is a High-Conviction Buy After the Drop Nov 14, 2026 Equinox Gold: Orla Deal Sparks a Multi-Stage Re-Rate — A Long Trade with Clear Risk Controls Nov 14, 2026 uniQure: Betting on a High-Risk, High-Reward Path to a Huntington's Breakthrough Nov 14, 2026 NESR: Ride the Jafurah Ramp-Up — Tactical Buy Into Recovery Nov 14, 2026